Transcatheter aortic valve implantation under extracorporeal membrane oxygenation

Close metadata

Recommended articles:

Conduction disturbances after transcatheter aortic valve implantation. Russian Cardiology Bulletin. 2023;(4):19-26

Left ventricular unloading during venoarterial extracorporeal membrane oxygenation. Russian Journal of Anesthesiology and Reanimatology. 2024;(1):74-80

Retrospective analysis of prenatal diagnosis and catamnesis data of children with congenital diaphragmatic hernia. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):68-73

Pulmonary high-frequency percussion ventilation in a patient with an extremely severe course of a new coronavirus infection. Russian Journal of Anesthesiology and Reanimatology. 2024;(3):81-86

Transcatheter aortic valve implantation in patients with bicuspid aortic valve. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):306-312

Three-year results of aortic valve neocuspidization (Ozaki procedure): a multiple-center retrospective study. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):428-435

Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):489-498

Transcatheter aortic valve implantation (TAVI) has become the standard treatment for advanced age and high risk patients with severe aortic stenosis. The incidence of life-threatening complications during TAVI has significantly decreased over the last decade due to advanced current surgical experience. However, there is a risk of perioperative life-threatening complications which can require emergency hemodynamic support. Veno-arterial extracorporeal membrane oxygenation (ECMO) may represent an effective strategy for immediate hemodynamic stabilization until further treatment of the underlying complication. It is presented case report of TAVI under ECMO performed at the Kemerovo Research Institute for Complex Issues of Cardiovascular Diseases. Emergency ECMO represents a feasible strategy for stabilization until further treatment of life-threatening complications during TAVI.

Keywords:

aortic valve

transcatheter aortic valve implantation

extracorporeal membrane oxygenation

Authors:

Kochergin N.A.

Research Institute of Complex Problems of Cardiovascular Diseases, Kemerovo, Russia

Vakkosov K.M.

State Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Boulevard, Kemerovo, Russia

Ganjukov V.I.

State Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Boulevard, Kemerovo, Russia

Tarasov R.S.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Shloydo E.A.

Clinical Hospital №2, St. Petersburg, Russia

List of references:

Gajfulin RA, Sumin AN, Ivanov SV, Barbarash LS. Survival after surgical treatment of multifocal atherosclerosis in different age groups. Complex Issues of Cardiovascular Diseases. 2017;2(6):6-18. (In Russ.)
Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187-2198. https://doi.org/10.12968/bjca.2011.6.11.564a
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-1620. https://doi.org/10.1056/NEJMoa1514616
Waksman R, Pichard AD. Will TAVR become the default treatment for patients with severe aortic stenosis? J Am Coll Cardiol. 2015;66:122-124. https://doi.org/10.1016/j.jacc.2015.05.016
Husser O, Pellegrini C, Kessler T, et al. Outcomes after transcatheter aortic valve replacement using a novel balloonexpandable transcatheter heart valve: A single-center experience. JACC Cardiovasc Interv. 2015;8:1809-1816. https://doi.org/10.1016/j.jcin.2015.08.01
Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis. Lancet. 2016;387:2218-2225. https://doi.org/10.1016/S0140-6736(16)30073-3
Eggebrecht H, Bestehorn M, Haude M, et al. Outcomes of transfemoral transcatheter aortic valve implantation at hospitals with and without on-site cardiac surgery department: Insights from the prospective German aortic valve replacement quality assurance registry (AQUA) in 17 919 patients. Eur Heart J. 2016;37:2240-2248. https://doi.org/10.1093/eurheartj/ehw190
Kuck KH, Eggebrecht H, Figulla HR, et al. Quality criteria on the implementation of transcatheter aortic valve implantation (TAVI). Position paper of the German Society of Cardiology. Der Kardiol. 2015;9:11-26. https://doi.org/10.1016/j.jcin.2012.04.001
Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59:1200-1254. https://doi.org/10.1016/j.athoracsur.2012.01.084
Husser O, Holzamer A, Philipp A, et al. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2013;82:E542-E551. https://doi.org/10.1002/ccd.24806
Seco M, Forrest P, Jackson SA, et al. Extracorporeal membrane oxygenation for very high-risk transcatheter aortic valve implantation. Heart Lung Circ. 2014;23:957-962. https://doi.org/10.1016/j.hlc.2014.05.006
Singh V, Patel SV, Savani C, et al. Mechanical circulatory support devices and transcatheter aortic valve implantation (from the National Inpatient Sample). Am J Cardiol. 2015;116:1574-1580. https://doi.org/10.1016/j.amjcard.2015.08.020
Trenkwalder T, Pellegrini C, Holzamer A, et al. Emergency extracorporeal membrane oxygenation in transcatheter aortic valve implantation: A two-center experience of incidence, outcome and temporal trends from 2010 to 2015. Catheter Cardiovasc Interv. 2017;00:1-8. https://doi.org/10.1002/ccd.27385
Bax JJ, Delgado V, Bapat V, et al. Open issues in transcatheter aortic valve implantation. Part 1: Patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J. 2014;35:2627-2638. https://doi.org/10.1093/eurheartj/ehu257
Tamborini G, Fusini L, Gripari P, et al. Feasibility and accuracy of 3DTEE versus CT for the evaluation of aortic valve annulus to left main ostium distance before transcatheter aortic valve implantation. JACC Cardiovasc Imaging. 2012;5:579-588. https://doi.org/10.1016/j.jcmg.2012.02.012
Husser O, Holzamer A, Resch M, et al. Prosthesis sizing for transcatheter aortic valve implantation. Comparison of three dimensional transesophageal echocardiography with multislice computed tomography. Int J Cardiol. 2013;168:3431-3438. https://doi.org/10.1016/j.ijcard.2013.04.182
Seiffert M, Conradi L, Baldus S, et al. Severe intraprocedural complications after transcatheter aortic valve implantation: Calling for a heart team approach. Eur J Cardiothorac Surg. 2013;44:478-484. https://doi.org/10.1093/ejcts/ezt032
Walther T, Hamm CW, Schuler G, et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: Prospective data from the GARY registry. J Am Coll Cardiol. 2015;65:2173-2180. https://doi.org/10.1016/j.jacc.2015.03.034
Hein R, Abdel-Wahab M, Sievert H, et al. Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery. EuroIntervention. 2013;9:446-451. https://doi.org/10.4244/EIJV9I4A73
Toutouzas K, Synetos A, Latsios G, et al. The requirement of extracorporeal circulation system for transluminal aortic valve replacement: Do we really need it in the catheterization laboratory? Catheter Cardiovasc Interv. 2015. https://doi.org/10.1002/ccd.25988
Makkar RR, Jilaihawi H, Chakravarty T, et al. Determinants and outcomes of acute transcatheter valve-in-valve therapy or embolization: A study of multiple valve implants in the U.S. PARTNER trial (Placement of AoRTic TraNscathetER Valve Trial Edwards SAPIEN Transcatheter Heart Valve). J Am Coll Cardiol. 2013;62:418-430. https://doi.org/10.1016/j.jacc.2013.04.037
Kodali S, Thourani VH, White J, et al. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediaterisk patients with aortic stenosis. Eur Heart J. 2016;37:2252-2262. https://doi.org/10.1093/eurheartj/ehw112
Shreenivas SS, Lilly SM, Szeto WY, et al. Cardiopulmonary bypass and intra-aortic balloon pump use is associated with higher short and long term mortality after transcatheter aortic valve replacement: A PARTNER trial substudy. Catheter Cardiovasc Interv. 2015;86:316-322. https://doi.org/10.1002/ccd.25776
Singh V, Damluji AA, Mendirichaga R, et al. Elective or emergency use of mechanical circulatory support devices during transcatheter aortic valve replacement. J Interv Cardiol. 2016;29:513-522. https://doi.org/10.1111/joic.12323
Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2014;35:156-167. https://doi.org/10.1093/eurheartj/eht248
Ribeiro HB, Nombela-Franco L, Urena M, et al. Coronary obstruction following transcatheter aortic valve implantation: A systematic review. JACC Cardiovasc Interv. 2013;6:452-461. https://doi.org/10.1016/j.jcin.2012.11.014
Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128:244-253. https://doi.org/10.1161/CIRCULATIONAHA.113.002947
Aubron C, Cheng AC, Pilcher D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: A 5- year cohort study. Crit Care. 2013;17:R73-R85. https://doi.org/10.1186/cc12681

Close metadata